Elisabeth Bjork - 26 Sep 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork
Issuer symbol
RCKT
Transactions as of
26 Sep 2024
Net transactions value
$0
Form type
4
Filing time
29 Oct 2024, 17:05:38 UTC
Previous filing
20 Jun 2024
Next filing
18 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +607 $0.000000 607 26 Sep 2024 Common Stock 607 $17.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 607 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on September 26, 2025.